Skip to main content

Time to identify and define non-tuberculous mycobacteria in a tuberculosis-endemic region

Buy Article:

$34.78 + tax (Refund Policy)

OBJECTIVE: To identify and characterise disease caused by non-tuberculous mycobacteria (NTM) in a tuberculosis-endemic region.

MATERIAL AND METHODS: A total of 133 NTM isolates cultivated using Mycobacteria Growth Indicator Tube 960 (MGIT 960) plus Löwenstein-Jensen (LJ) and identified using the NAP and PNBA tests were screened to species level using molecular methods. The 360-base pair (bp) region of the rpoB gene was amplified and analysed using an in-house RLBH assay, PCR-RE and sequencing. The clinical significance of all isolated NTM was determined as per published guidelines.

RESULTS AND DISCUSSION: Of the 133 isolates, 127 were confirmed as NTM and six as Mycobacterium tuberculosis complex by molecular methods; 81% of the NTM were recovered from pulmonary and 19% from extra-pulmonary specimens. Among the rapidly growing NTM, M. fortuitum (41%) and M. abscessus (59%) were predominant. Among the slow growing NTM, 40% were identified as M. intracellulare, followed by M. simiae (35%), M. kansasii (6%), M. gordonae (4%) M. szulgai (2%) and M. avium (1%). Mixed infections were noted in 10 (12%) cases. In all, 58 (46%) NTM met clinical, radiological and microbiological criteria and were considered definite NTM infections, 33 (26%) were highly probable disease and 36 (28%) were possible disease or colonisation.

CONCLUSION: Overall, 72% of isolated NTM were found to be clinically significant. Accurate species identification and adherence to published guidelines help to outline pathogenicity.

Keywords: India; NTM; non-tuberculous mycobacteria; species identification

Document Type: Regular Paper

Affiliations: Department of Microbiology, P D Hinduja National Hospital & Medical Research Centre, Mahim (West), Mumbai, India

Publication date: 01 August 2010

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content